跳至主要内容
临床试验/IRCT201101245681N1
IRCT201101245681N1已完成4 期

Comparison of doxycycline-streptomycin, doxycycline-rifampin and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial

Vice-Chancellor of Research and Technology,Hamedan University of Medical sciences0 个研究点目标入组 191 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
191

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 65 years(—)
性别
All

入选标准

  • clinical presentations compatible with brucellosis in the presence of significant titers of specific antibodies (standard tube agglutination = 1/160, coomb’s test = 1/160, 2-mercaptoetanol = 1-80, or Brucella IgG-ELISA > 12) and/or a positive blood culture for Brucella
  • Exclusion criteria: age under 17 years, brucella endocarditis, neurobrucellosis, pregnancy, renal failure, hepatic failure, a history of treatment for brucellosis in the last six months

排除标准

  • 未提供

研究者

发起方
Vice-Chancellor of Research and Technology,Hamedan University of Medical sciences

相似试验